IGM Biosciences Inc (IGMS)

NASDAQ
26.77
+0.06(+0.21%)
  • Volume:
    65,857
  • Day's Range:
    26.36 - 27.24
  • 52 wk Range:
    12.67 - 83.60

IGMS Overview

Prev. Close
26.71
Day's Range
26.36-27.24
Revenue
366K
Open
26.36
52 wk Range
12.67-83.6
EPS
-5.66
Volume
65,857
Market Cap
1.14B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
261,241
P/E Ratio
-4.38
Beta
-0.263
1-Year Change
-64.64%
Shares Outstanding
42,656,845
Next Earnings Date
Nov 10, 2022
What is your sentiment on IGM Biosciences?
or
Vote to see community's results!

IGM Biosciences Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

IGM Biosciences Inc Company Profile

IGM Biosciences Inc Company Profile

Employees
192

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company’s lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin’s lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyBuyStrong BuySell
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Sell
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Sell
  • ready to fly
    0
    • omg
      0
      • I'm sure long term prospect is great for this company when it become profitable 2022
        0
        • Future biggest
          0